Ensysce Biosciences Inc Revenue per Employee (ENSC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ensysce Biosciences Inc   (NASDAQ: ENSC)
 

Ensysce Biosciences Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Ensysce Biosciences Inc 's Revenue per employee fell on a trailing twelve month basis to $ 470,788, but the productivity of Ensysce Biosciences Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 195 other companies have achieved higher revenue per employee. While Ensysce Biosciences Inc 's total ranking has deteriorated compared to the previous quarter from 1354 to 1565. Ensysce Biosciences Inc has 10 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENSC Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change -27.18 % 44.39 % -85.58 % 654.38 % 331.69 %
Sales per Employee (TTM) $ 470,788 506,665 448,797 741,372 622,408
ENSC's Total Ranking # 1565 # 1354 # 1356 # 968 # 1230
Seq. Revenue Change -48.95 % 281.73 % -64.04 % 3.91 % 1.24 %

ENSC Company Profile >> Back to ENSC Efficiency Comparisons >> Compare ENSC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 115
Healthcare Sector # 196
Overall Market # 1565

Revenue per Employee Statistics
High Average Low
$ 741,372 $ 318,017 $ -55,541
(Jun 30 2025)   (Sep 30 2022)



Financial Statements
Ensysce Biosciences Inc 's Revenue MRQ $ 1 Millions Visit ENSC's Income Statement
Ensysce Biosciences Inc 's Revenues TTM $ 5 Millions Visit ENSC's aggregate revenue growth
What are ENSC's Sales? Visit ENSC's Sales by Segment




Other Ratios
Ensysce Biosciences Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ENSC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ENSC's Competitors
Revenue per Employee for ENSC's Suppliers
Revenue per Employee for ENSC's Customers

You may also want to know
ENSC's Sales Growth Rates ENSC's Pe Price to earnings ratio ENSC's Receivables Turnover Ratio ENSC's Stock Quote
ENSC's Net Income Growth Rates ENSC's Ps Price to Sales ratio ENSC's Sales per Employee ENSC's Asset Turnover Ratio
ENSC's Net Margin ENSC's Pb Price to Book ratio ENSC's Financial Strength Ratios ENSC's Dividend Payout Ratio
Date modified: 2026-08-30T14:57:57+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Sanuwave Health Inc   805,963.64 $ 44.328  Million 55 
Xtant Medical Holdings Inc   801,331.13 $ 121.001  Million 151 
Novavax inc   796,178.91 $ 596.338  Million 749 
Marker Therapeutics inc   789,851.20 $ 3.949  Million 5 
Immunocore Holdings Plc  787,809.16 $ 412.812  Million 524 
Adma Biologics Inc   784,800.62 $ 507.766  Million 647 
Axsome Therapeutics Inc   765,660.54 $ 708.236  Million 925 
Alkermes Plc   762,097.56 $ 1,562.300  Million 2,050 
Dyadic International Inc   761,545.80 $ 3.808  Million 5 
Geron Corporation  759,135.66 $ 195.857  Million 258 
Emergent Biosolutions Inc   752,000.00 $ 676.800  Million 900 
Cerus Corporation  749,159.72 $ 215.758  Million 288 
Ionis Pharmaceuticals Inc   736,863.05 $ 1,033.082  Million 1,402 
Vericel Corporation  733,884.42 $ 292.086  Million 398 
Syndax Pharmaceuticals Inc   728,771.81 $ 217.174  Million 298 
Sutro Biopharma Inc   727,065.69 $ 99.608  Million 137 
Aveanna Healthcare Holdings Inc   720,540.00 $ 2,521.890  Million 3,500 
Sunshine Biopharma Inc   709,866.30 $ 35.493  Million 50 
Transmedics Group Inc   708,118.04 $ 635.890  Million 898 
Masimo Corp  707,727.27 $ 1,557.000  Million 2,200 
Xilio Therapeutics Inc   703,736.84 $ 53.484  Million 76 
Harrow Inc   700,458.12 $ 267.575  Million 382 
Evofem Biosciences Inc   697,827.59 $ 20.237  Million 29 
Bridgebio Pharma Inc   691,249.11 $ 579.958  Million 839 
Inspire Medical Systems inc   686,466.62 $ 915.060  Million 1,333 
Option Care Health Inc   685,528.31 $ 5,666.577  Million 8,266 
Johnson and Johnson  684,389.20 $ 96,362.000  Million 140,800 
Veracyte Inc   683,686.09 $ 516.183  Million 755 
Premier Air Charter Holdings Inc   677,662.12 $ 33.205  Million 49 
Precision Biosciences Inc  662,838.24 $ 45.073  Million 68 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.